LNC
DNA icon

Lincoln National Corp’s Ginkgo Bioworks DNA Stock Holding History

Lincoln National Corp’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-273
Closed -$12.7K – 285
2024
Q1 		$12.7K Sell
273
-2
-0.7% -$104 ﹤0.01% 1198
2023
Q4 		$18.6K Buy
275
+2
+0.7% +$122 ﹤0.01% 1096
2023
Q3 		$19.7K Sell
273
-50
-15% -$4K ﹤0.01% 1016
2023
Q2 		$24K Buy
323
+50
+18% +$2.96K ﹤0.01% 1008
2023
Q1 		$14.5K Sell
273
-12
-4% -$760 ﹤0.01% 978
2022
Q4 		$19.2K Buy
285
+9
+3% +$828 ﹤0.01% 919
2022
Q3 		$34K Hold
276
– – ﹤0.01% 861
2022
Q2 		$26K Buy
+276
New +$33.7K ﹤0.01% 854

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Lincoln National Corp's DNA Position: Q2 2024 in Review

Lincoln National Corp sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 273 shares — an estimated $12.7K sold.

Lincoln National Corp first reported a position in DNA in Q2 2022 and held it in 8 quarters. The position peaked at $34K in Q3 2022. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Lincoln National Corp reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 273 Ginkgo Bioworks shares in Q2 2024, an estimated $12.7K.
  • Lincoln National Corp first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 8 quarters.
  • Lincoln National Corp's Ginkgo Bioworks position peaked at $34K in Q3 2022.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.